信息素技术再突破：ISCA、Pheronym、中捷四方共探生态诱控新边界
编者按 ：信息素技术正逐步成长为农业绿色防控体系中的重要力量。本期访谈特邀来自 ISCA、Pheronym 和中捷四方的三位行业代表，围绕信息素产品的创新突破、缓释技术进展、市场痛点及与生物农药协同应用等议题展开深度对话。三家企业从不同技术路径出发，共同描绘了信息素技术从高价值作物走向大田生产，从地上害虫拓展至土壤有害生物的广阔前景，为行业发展提供了宝贵的实践洞见。
The biggest biotech funding rounds in July 2026
The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in more detail.
Alliance One Introduces Proprietary Tobacco Seed Varieties in Tanzania
August 2026, Morrisville: Alliance One International, LLC is advancing agricultural innovation in Tanzania through its A…
Indoor ag heavyweight 80 Acres Farms to cease operations
US-based indoor farming startup 80 Acres Farms will cease operations, AgFunderNews has learned. Cofounder and CEO Mike Z…
World Food Safety Day / Ecuador Food Employees Encouraged To Develop Food Safety Improvements
August 2026, Rome: To celebrate World Food Safety Day at Starkist, a seafood production company, employees were encourag…
Immune Pathway Identified That Prevents C. albicans Infection from Becoming Deadly
King’s College London researchers have identified an immune pathway that prevents what is normally a harmless fungus, Candida albicans, from developing into a fatal infection.
Federal Court Sides with the Public’s Right to Know in GMO/Bioengineered Food Labeling Case
August 2026, San Francisco: In a major victory for consumers and food right-to-know advocates, a federal district handed…
Electrical Stimulation’s Effects on Neurons, Gene Expression Mapped in Living Human Brain Tissue
Neurons from living human brain tissue have helped researchers trace how electrical stimulation reshapes brain cell communication and gene activity—work that could guide more precise neuromodulation strategies for cognitive decline and other neurological conditions in the future.
Enzene Targets Local Biomanufacturing with New Solutions
CDMO Enzene launched NeX™, which it labels “an end-to-end partnership model that enables governments, institutions, and biopharma organizations to establish world-class biomanufacturing capabilities wherever they need them.”
Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion and Genentech to co-develop a neuroscience small molecule early discovery program based on the first validated target discovered through an AI map they created to find new targets in a long-challenging therapeutic area.